United States · FDA National Drug Code directory

Influenzinum 200C

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 44911-0905_7d7554b1-6f99-46b9-9be4-c6054577087f
Product NDC: 44911-0905
Form: LIQUID
Composition / generic term: Influenzinum (2025-2026)
Labeler: Energique, Inc.
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start / end (source format): 20260415
Source listing expiry: 20271231

Source-listed ingredients

INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED) — 200 [hp_C]/mL
INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED) — 200 [hp_C]/mL
INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED) — 200 [hp_C]/mL

These values do not establish equivalence or a dose recommendation.

Packages

30 mL in 1 BOTTLE, DROPPER (44911-0905-1) · 44911-0905-1

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →